THO KIRKLAND: Open Payments
NPI 1306456637 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 57 payments from 10 companies in 2025. Trend: 2023 $460 · 2024 $591 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $446 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $122 |
| Aimmune Therapeutics, Inc. | 6 | $107 |
| PFIZER INC. | 4 | $67 |
| Janssen Biotech, Inc. | 3 | $42 |
| Madrigal Pharmaceuticals | 1 | $41 |
| Phathom Pharmaceuticals, Inc. | 5 | $34 |
| Gilead Sciences, Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: RINVOQ, ENTYVIO, ZENPEP, SKYRIZI, XELJANZ, LINZESS, MAVYRET, TREMFYA.
Industry payments across FL — which companies pay providers there.
